MEHMET OKCU

Concepts (522)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rhabdomyosarcoma
15
2025
190
4.160
Why?
Medulloblastoma
23
2024
325
3.390
Why?
Cerebellar Neoplasms
21
2024
275
3.270
Why?
Proton Therapy
22
2024
123
3.070
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
2020
781
2.680
Why?
Craniospinal Irradiation
10
2023
58
2.030
Why?
Cancer Survivors
15
2024
209
1.960
Why?
Antineoplastic Combined Chemotherapy Protocols
13
2024
1214
1.910
Why?
Brain Neoplasms
26
2024
1212
1.900
Why?
Prolotherapy
2
2023
2
1.660
Why?
Tennis Elbow
2
2023
2
1.660
Why?
Rhabdomyosarcoma, Embryonal
5
2024
51
1.540
Why?
Soft Tissue Neoplasms
5
2022
122
1.500
Why?
Neoplasm Recurrence, Local
13
2024
1140
1.440
Why?
Child
114
2025
24383
1.350
Why?
Child, Preschool
76
2025
14018
1.210
Why?
Polymorphism, Genetic
6
2011
812
1.110
Why?
Photons
5
2021
48
1.070
Why?
Glioma
10
2024
491
1.000
Why?
Adolescent
80
2025
19284
0.990
Why?
Survivors
20
2024
335
0.980
Why?
Pituitary Neoplasms
5
2023
80
0.970
Why?
Nocardia Infections
1
2024
14
0.880
Why?
Infant
46
2025
12475
0.870
Why?
Salvage Therapy
2
2024
192
0.870
Why?
Neoplasms
17
2024
2788
0.870
Why?
Humans
144
2025
124725
0.790
Why?
Fibroma
1
2022
29
0.790
Why?
Sarcoma
2
2022
183
0.780
Why?
Central Nervous System Neoplasms
5
2023
196
0.760
Why?
Cranial Irradiation
6
2020
67
0.740
Why?
Female
105
2025
66569
0.740
Why?
Male
101
2025
61269
0.730
Why?
Glutathione Transferase
5
2013
153
0.710
Why?
Hearing Loss
4
2024
134
0.680
Why?
Diagnostic Imaging
3
2022
276
0.680
Why?
Sarcoma, Synovial
4
2024
21
0.670
Why?
Radiotherapy, Intensity-Modulated
7
2017
71
0.650
Why?
Head and Neck Neoplasms
7
2021
502
0.650
Why?
Genetic Predisposition to Disease
11
2023
3154
0.650
Why?
Scoliosis
1
2021
135
0.640
Why?
Genotype
13
2016
2556
0.630
Why?
Birth Weight
5
2015
346
0.630
Why?
Cisplatin
7
2024
236
0.610
Why?
Retrospective Studies
42
2024
16335
0.590
Why?
Ependymoma
6
2023
125
0.570
Why?
Protons
8
2023
92
0.550
Why?
Radiotherapy Dosage
12
2023
183
0.540
Why?
Polymorphism, Single Nucleotide
11
2020
2634
0.530
Why?
Cognition
8
2023
722
0.520
Why?
Prognosis
19
2025
4627
0.520
Why?
Biomarkers, Tumor
9
2025
1486
0.510
Why?
Radiotherapy
3
2014
135
0.510
Why?
Survivorship
4
2024
36
0.500
Why?
Cognition Disorders
7
2017
553
0.500
Why?
Neoplasm, Residual
5
2013
123
0.490
Why?
Glutathione S-Transferase pi
3
2012
25
0.480
Why?
Combined Modality Therapy
13
2021
1233
0.470
Why?
Adult
37
2025
29488
0.470
Why?
Carcinoma
1
2017
286
0.470
Why?
Craniopharyngioma
4
2023
33
0.470
Why?
Disease-Free Survival
14
2018
873
0.460
Why?
Antineoplastic Agents
13
2024
1662
0.450
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
2
2011
70
0.450
Why?
Adaptation, Psychological
3
2024
444
0.440
Why?
Follow-Up Studies
16
2024
5161
0.440
Why?
Cost Savings
1
2014
71
0.430
Why?
Risk Factors
19
2024
10286
0.420
Why?
Mutism
2
2024
27
0.410
Why?
Proportional Hazards Models
10
2025
1356
0.410
Why?
Kaplan-Meier Estimate
9
2021
1037
0.400
Why?
DNA Methylation
5
2020
1006
0.400
Why?
Folic Acid
2
2012
293
0.390
Why?
Quality of Health Care
1
2015
390
0.390
Why?
Ambulatory Care
1
2015
387
0.390
Why?
Bone Marrow
2
2021
324
0.380
Why?
Young Adult
20
2024
9023
0.380
Why?
Neuroblastoma
5
2010
520
0.380
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2021
129
0.360
Why?
Anemia, Iron-Deficiency
2
2024
136
0.360
Why?
Rhabdomyosarcoma, Alveolar
3
2021
36
0.360
Why?
Ultrasonography, Interventional
2
2023
191
0.360
Why?
Radiation Injuries
7
2021
142
0.350
Why?
Attention
3
2019
200
0.340
Why?
Metabolic Networks and Pathways
1
2011
187
0.340
Why?
Treatment Outcome
17
2023
12356
0.330
Why?
Intelligence
3
2023
98
0.330
Why?
Body Height
1
2010
215
0.320
Why?
Models, Genetic
2
2014
759
0.320
Why?
Hypothyroidism
2
2021
91
0.310
Why?
Attention Deficit Disorder with Hyperactivity
2
2011
224
0.310
Why?
Cochlea
2
2024
85
0.310
Why?
Survival Rate
8
2024
2047
0.300
Why?
Glucose
2
2023
875
0.300
Why?
Urogenital Neoplasms
1
2008
15
0.290
Why?
Methylenetetrahydrofolate Dehydrogenase (NAD+)
1
2007
3
0.290
Why?
Genetic Markers
3
2015
604
0.280
Why?
Hodgkin Disease
2
2024
294
0.270
Why?
Disease Progression
6
2023
2049
0.270
Why?
Proto-Oncogene Proteins
3
2022
545
0.260
Why?
Case-Control Studies
12
2015
3284
0.250
Why?
Bone Neoplasms
3
2022
420
0.240
Why?
Intervertebral Disc Displacement
1
2025
19
0.240
Why?
Texas
11
2023
3585
0.240
Why?
Osteosarcoma
2
2022
253
0.230
Why?
Histocompatibility Antigens Class I
2
2015
97
0.230
Why?
Margins of Excision
1
2024
53
0.230
Why?
Aftercare
2
2017
147
0.230
Why?
Cervical Vertebrae
1
2025
114
0.230
Why?
Repressor Proteins
2
2022
815
0.220
Why?
Costs and Cost Analysis
2
2015
164
0.220
Why?
Intelligence Tests
3
2022
57
0.220
Why?
Menorrhagia
1
2024
75
0.210
Why?
Isoenzymes
1
2004
229
0.210
Why?
Germinoma
1
2023
30
0.210
Why?
Algorithms
2
2024
1622
0.210
Why?
Medical Oncology
3
2011
213
0.210
Why?
Leuprolide
1
2023
22
0.210
Why?
Ovarian Reserve
1
2023
11
0.210
Why?
Obesity
3
2020
2245
0.210
Why?
Vincristine
4
2021
191
0.200
Why?
Epoxide Hydrolases
2
2013
37
0.200
Why?
Hand Strength
1
2022
40
0.200
Why?
Cognitive Dysfunction
2
2023
238
0.200
Why?
Patient Preference
1
2023
118
0.200
Why?
Tracheostomy
1
2024
192
0.200
Why?
Antineoplastic Agents, Alkylating
4
2021
99
0.190
Why?
Neuroectodermal Tumors, Primitive
2
2012
50
0.190
Why?
Tooth Abnormalities
1
2021
9
0.190
Why?
Xerostomia
1
2021
8
0.190
Why?
Cerebellar Diseases
1
2022
73
0.190
Why?
Fever
1
2024
296
0.180
Why?
Salivary Glands
1
2021
33
0.180
Why?
Adrenal Insufficiency
1
2021
28
0.180
Why?
Multivariate Analysis
6
2017
1435
0.180
Why?
Drug Costs
1
2021
61
0.180
Why?
Cyclophosphamide
3
2021
418
0.180
Why?
Paresis
1
2021
35
0.180
Why?
Optic Nerve Glioma
1
2021
21
0.180
Why?
Caregivers
2
2023
575
0.180
Why?
Hemiplegia
1
2021
45
0.180
Why?
Granuloma, Giant Cell
1
2020
13
0.180
Why?
Denosumab
1
2020
13
0.180
Why?
Sarcoma, Ewing
1
2022
107
0.180
Why?
Language Development Disorders
1
2022
174
0.180
Why?
Adult Survivors of Child Adverse Events
1
2020
14
0.180
Why?
Gadolinium
1
2021
106
0.170
Why?
Neuropsychological Tests
6
2024
924
0.170
Why?
Bone Density Conservation Agents
1
2020
51
0.170
Why?
Dactinomycin
2
2021
66
0.170
Why?
Iron
1
2022
266
0.170
Why?
Radiotherapy, Adjuvant
5
2023
144
0.170
Why?
Immunosuppressive Agents
1
2024
649
0.170
Why?
Carboplatin
2
2017
76
0.160
Why?
Incidence
3
2022
3142
0.160
Why?
Emergency Service, Hospital
2
2024
1089
0.160
Why?
Neurofibromatosis 1
1
2020
60
0.160
Why?
Pain
1
2022
461
0.160
Why?
Neurocognitive Disorders
1
2019
67
0.160
Why?
Metabolome
1
2021
293
0.160
Why?
Neurosurgical Procedures
2
2023
304
0.160
Why?
Infant, Newborn
7
2017
8191
0.150
Why?
Genetic Variation
3
2015
1497
0.150
Why?
Treatment Failure
5
2021
337
0.150
Why?
Memory, Short-Term
1
2019
140
0.150
Why?
Randomized Controlled Trials as Topic
1
2023
1111
0.150
Why?
Membrane Proteins
3
2015
1532
0.150
Why?
Glioblastoma
4
2006
330
0.150
Why?
Social Class
1
2019
190
0.150
Why?
Hearing Loss, Sensorineural
1
2019
141
0.150
Why?
Sarcoma, Alveolar Soft Part
1
2018
10
0.150
Why?
Radiotherapy, Conformal
2
2008
55
0.150
Why?
Metabolomics
1
2021
423
0.150
Why?
Postoperative Complications
4
2024
3071
0.150
Why?
Urinary Bladder Neoplasms
2
2021
557
0.150
Why?
Morbidity
3
2024
247
0.140
Why?
Human Growth Hormone
1
1998
74
0.140
Why?
Polymerase Chain Reaction
3
2008
1586
0.140
Why?
Superoxide Dismutase
2
2015
137
0.140
Why?
Middle Aged
11
2025
26797
0.140
Why?
Cushing Syndrome
1
2017
16
0.140
Why?
Leucovorin
1
2017
49
0.140
Why?
Activities of Daily Living
1
2019
402
0.140
Why?
Body Mass Index
2
2020
1563
0.140
Why?
Neoplasm Staging
5
2019
1251
0.140
Why?
p21-Activated Kinases
1
2017
57
0.140
Why?
Brain Stem
2
2015
115
0.140
Why?
Fluorouracil
1
2017
127
0.140
Why?
HLA-DQ alpha-Chains
1
2016
17
0.140
Why?
Appendiceal Neoplasms
1
2017
18
0.130
Why?
Hyperglycemia
2
2009
222
0.130
Why?
Registries
3
2019
1434
0.130
Why?
Logistic Models
3
2010
1812
0.130
Why?
Myelodysplastic Syndromes
1
1998
140
0.130
Why?
Xeroderma Pigmentosum Group D Protein
1
2016
21
0.130
Why?
Consensus Development Conferences as Topic
1
2016
39
0.130
Why?
Age Factors
5
2024
2820
0.130
Why?
DNA, Neoplasm
2
2016
301
0.130
Why?
Executive Function
1
2017
110
0.130
Why?
Neuroendocrine Tumors
1
2017
54
0.130
Why?
United States
6
2022
10899
0.130
Why?
Growth Disorders
1
1998
209
0.130
Why?
Odds Ratio
5
2015
1259
0.130
Why?
Stroke
1
2023
986
0.120
Why?
Recurrence
3
2023
1421
0.120
Why?
Ear Diseases
1
2015
18
0.120
Why?
Carcinoma, Mucoepidermoid
1
2015
13
0.120
Why?
Bone Marrow Transplantation
1
1998
573
0.120
Why?
Anthracyclines
1
2015
36
0.120
Why?
Prospective Studies
6
2025
6147
0.120
Why?
Brain
4
2023
2982
0.120
Why?
Bone Marrow Examination
2
2005
14
0.120
Why?
Oncogene Proteins, Fusion
2
2015
209
0.120
Why?
Oncogene Fusion
1
2014
22
0.120
Why?
Cyclin B
1
2014
22
0.120
Why?
Iron-Regulatory Proteins
1
2014
5
0.120
Why?
Neoplasm Proteins
3
2018
669
0.110
Why?
Antibiotics, Antineoplastic
1
2015
126
0.110
Why?
Survival Analysis
5
2008
1499
0.110
Why?
Rhabdoid Tumor
1
2014
47
0.110
Why?
Health Services
1
2014
71
0.110
Why?
Filgrastim
1
2014
15
0.110
Why?
Decision Trees
1
2014
49
0.110
Why?
Prostatic Neoplasms
2
2021
1548
0.110
Why?
Tumor Suppressor Proteins
1
2016
465
0.110
Why?
Monte Carlo Method
1
2014
95
0.110
Why?
Outpatients
1
2015
252
0.110
Why?
Granulocyte Colony-Stimulating Factor
1
2014
95
0.110
Why?
Infant Food
1
2013
81
0.110
Why?
Teratoma
1
2014
121
0.110
Why?
Leukemia
2
2010
369
0.110
Why?
Amifostine
2
2010
14
0.110
Why?
Overweight
1
2016
364
0.110
Why?
Consensus
1
2016
646
0.100
Why?
Multicenter Studies as Topic
1
2014
275
0.100
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
43
0.100
Why?
Stroke Volume
1
2015
488
0.100
Why?
Patient Acceptance of Health Care
1
2017
422
0.100
Why?
Biomarkers
1
2021
3067
0.100
Why?
Anti-Bacterial Agents
1
2024
2428
0.100
Why?
Hydrocarbons, Chlorinated
1
2012
11
0.100
Why?
Air Pollutants, Occupational
1
2012
18
0.100
Why?
Telomere
1
2013
213
0.100
Why?
Neoplasms, Second Primary
1
2013
153
0.100
Why?
Ventricular Dysfunction, Left
1
2015
366
0.100
Why?
Surgical Procedures, Operative
1
2014
184
0.100
Why?
Immunohistochemistry
3
2012
1690
0.100
Why?
Genome-Wide Association Study
4
2023
1684
0.100
Why?
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
1
2011
21
0.090
Why?
Haplotypes
1
2013
522
0.090
Why?
Gene-Environment Interaction
1
2012
121
0.090
Why?
Thyroid Neoplasms
1
2013
190
0.090
Why?
Inpatients
1
2015
496
0.090
Why?
Papillomavirus Vaccines
1
2012
94
0.090
Why?
Liposarcoma
1
2011
22
0.090
Why?
Time Factors
4
2024
6308
0.090
Why?
Computer Simulation
1
2014
646
0.090
Why?
Vaccination
1
2016
955
0.090
Why?
Decision Support Techniques
1
2014
292
0.090
Why?
Social Adjustment
2
2022
83
0.090
Why?
Mitogen-Activated Protein Kinase Phosphatases
1
2010
15
0.090
Why?
Chemokines, CXC
1
2010
38
0.090
Why?
Nervous System Diseases
3
2013
375
0.090
Why?
Dual-Specificity Phosphatases
1
2010
22
0.090
Why?
Heart Ventricles
1
2015
762
0.090
Why?
Air Pollutants
1
2012
101
0.090
Why?
Gestational Age
2
2015
1158
0.090
Why?
Recombinant Proteins
1
2014
1390
0.090
Why?
Neoplasm Metastasis
3
2017
669
0.080
Why?
Risk Assessment
2
2014
3447
0.080
Why?
Fetal Macrosomia
1
2010
20
0.080
Why?
Prodrugs
1
2010
59
0.080
Why?
Pediatrics
2
2011
1166
0.080
Why?
Antioxidants
1
2012
335
0.080
Why?
Dacarbazine
1
2009
83
0.080
Why?
Information Dissemination
1
2011
186
0.080
Why?
Tumor Burden
2
2021
230
0.080
Why?
Nerve Sheath Neoplasms
1
2009
23
0.080
Why?
Magnetic Resonance Imaging
4
2021
3556
0.080
Why?
Clinical Trials as Topic
1
2014
1090
0.080
Why?
Uterine Cervical Neoplasms
1
2012
237
0.080
Why?
Oligodendroglioma
2
2010
22
0.080
Why?
In Situ Hybridization, Fluorescence
2
2013
762
0.080
Why?
Practice Guidelines as Topic
2
2024
1269
0.080
Why?
Astrocytoma
2
2013
99
0.080
Why?
Parents
2
2023
1014
0.080
Why?
Carmustine
2
1999
26
0.080
Why?
Ethics, Medical
1
2011
395
0.080
Why?
Spinal Cord Neoplasms
1
2009
71
0.080
Why?
Papillomavirus Infections
1
2012
293
0.080
Why?
Surveys and Questionnaires
3
2023
3716
0.070
Why?
Cyclins
2
1999
101
0.070
Why?
Real-Time Polymerase Chain Reaction
3
2015
502
0.070
Why?
Quality of Life
3
2023
1935
0.070
Why?
Neutropenia
1
2009
200
0.070
Why?
Sex Distribution
2
2013
303
0.070
Why?
Folic Acid Antagonists
1
2007
16
0.070
Why?
Thrombocytopenia
1
2009
221
0.070
Why?
Quality Improvement
2
2024
640
0.070
Why?
Sex Characteristics
1
2009
311
0.070
Why?
Cross-Sectional Studies
4
2019
3432
0.070
Why?
Syndrome
2
2022
1119
0.070
Why?
Lung Neoplasms
1
2017
1659
0.070
Why?
Radiation Oncology
1
2007
23
0.070
Why?
Remission Induction
2
2008
299
0.070
Why?
Guidelines as Topic
1
2008
197
0.070
Why?
Antimetabolites, Antineoplastic
1
2007
184
0.060
Why?
Hospitalization
1
2014
1779
0.060
Why?
Risk
2
2019
755
0.060
Why?
Tumor Suppressor Protein p53
1
2010
723
0.060
Why?
Biomedical Research
1
2011
519
0.060
Why?
Apoptosis
5
2010
1790
0.060
Why?
Chemotherapy, Adjuvant
2
2010
361
0.060
Why?
Vision Disorders
2
2021
211
0.060
Why?
Injections, Epidural
1
2025
6
0.060
Why?
Flow Cytometry
2
2005
797
0.060
Why?
Methotrexate
1
2007
341
0.060
Why?
Telomerase
1
2006
160
0.060
Why?
Hemochromatosis Protein
2
2015
22
0.060
Why?
Predictive Value of Tests
3
2008
2156
0.060
Why?
Mental Disorders
1
2012
820
0.060
Why?
Immunophenotyping
1
2005
330
0.060
Why?
Cohort Studies
4
2019
4806
0.060
Why?
Bone Marrow Neoplasms
1
2004
23
0.060
Why?
Age Distribution
2
2002
415
0.060
Why?
Receptors, CXCR4
1
2004
57
0.060
Why?
Polymorphism, Restriction Fragment Length
1
2004
143
0.060
Why?
Radiotherapy Planning, Computer-Assisted
2
2014
63
0.050
Why?
Chemoradiotherapy
1
2024
105
0.050
Why?
Sensitivity and Specificity
2
2005
2050
0.050
Why?
Genomics
1
2011
1501
0.050
Why?
Antigens, CD
1
2005
420
0.050
Why?
Linear Models
2
2016
676
0.050
Why?
Genes, Immunoglobulin
1
2003
33
0.050
Why?
Chromosomes, Human, Pair 17
1
2005
369
0.050
Why?
Tennessee
1
2003
27
0.050
Why?
Italy
1
2003
97
0.050
Why?
Germany
1
2003
65
0.050
Why?
Anti-Mullerian Hormone
1
2023
37
0.050
Why?
Chromosome Aberrations
1
2005
616
0.050
Why?
Verbal Learning
1
2022
66
0.050
Why?
Time-to-Treatment
1
2024
186
0.050
Why?
Neoplasm Grading
2
2013
274
0.050
Why?
Pulmonary Artery
1
2005
442
0.050
Why?
Confidence Intervals
1
2002
285
0.050
Why?
Probability
1
2002
320
0.050
Why?
Respiration, Artificial
1
2024
460
0.050
Why?
Precision Medicine
1
2025
319
0.050
Why?
Anemia, Sickle Cell
1
2005
338
0.050
Why?
Spinal Cord
1
2023
300
0.050
Why?
RNA, Messenger
5
2009
2814
0.050
Why?
Lymphatic Metastasis
2
2018
414
0.050
Why?
Hemoglobins
1
2022
304
0.050
Why?
Emotions
1
2024
352
0.050
Why?
Neoadjuvant Therapy
1
2023
337
0.050
Why?
Genetic Association Studies
2
2015
778
0.050
Why?
Growth Hormone
1
2021
150
0.050
Why?
Reoperation
1
2024
833
0.050
Why?
Reference Values
1
2002
711
0.050
Why?
Cancer Care Facilities
2
2016
31
0.040
Why?
Hypertension, Pulmonary
1
2005
436
0.040
Why?
Severity of Illness Index
1
2009
2895
0.040
Why?
Analysis of Variance
2
2015
1016
0.040
Why?
Disease Management
1
2024
524
0.040
Why?
Research
1
2022
263
0.040
Why?
Alleles
2
2015
1613
0.040
Why?
Genes, bcl-2
1
1999
9
0.040
Why?
Population Surveillance
1
2002
388
0.040
Why?
Proctitis
1
2019
6
0.040
Why?
Leukemia, Myeloid
1
1999
85
0.040
Why?
Tretinoin
1
1999
116
0.040
Why?
Oligodeoxyribonucleotides, Antisense
1
1999
7
0.040
Why?
Adiposity
1
2020
190
0.040
Why?
Urinary Incontinence
1
2019
70
0.040
Why?
Cost-Benefit Analysis
1
2021
509
0.040
Why?
Cell Line, Tumor
3
2010
3335
0.040
Why?
Cystectomy
1
2019
160
0.040
Why?
Seizures
1
2023
872
0.040
Why?
Leukocyte Count
1
2019
250
0.040
Why?
Photic Stimulation
1
2019
223
0.040
Why?
Lymphatic Irradiation
1
2018
5
0.040
Why?
Relative Biological Effectiveness
1
2018
6
0.040
Why?
Psychomotor Performance
1
2019
182
0.040
Why?
Drug Resistance, Multiple
1
1998
48
0.040
Why?
Interleukin-10
1
1999
172
0.040
Why?
Prostatectomy
1
2019
344
0.040
Why?
DNA-Binding Proteins
1
2006
2043
0.040
Why?
Contrast Media
1
2021
473
0.040
Why?
Pregnancy
3
2015
7178
0.030
Why?
Tumor Cells, Cultured
4
1999
1062
0.030
Why?
Lymphocytes
1
2019
406
0.030
Why?
Neoplasms, Germ Cell and Embryonal
1
2017
87
0.030
Why?
Membrane Glycoproteins
1
1999
409
0.030
Why?
Computational Biology
1
2021
811
0.030
Why?
Colectomy
1
2017
74
0.030
Why?
Neutrophils
1
2019
381
0.030
Why?
Visual Acuity
1
2021
817
0.030
Why?
Prevalence
2
2016
2447
0.030
Why?
Appendectomy
1
2017
85
0.030
Why?
Incidental Findings
1
2017
126
0.030
Why?
Radiation Dosage
1
2016
135
0.030
Why?
Aged
5
2014
19764
0.030
Why?
Sample Size
1
2016
86
0.030
Why?
Longitudinal Studies
1
2019
1328
0.030
Why?
Lymph Nodes
1
2018
382
0.030
Why?
Appendicitis
1
2017
126
0.030
Why?
Hematopoietic Stem Cells
1
1999
536
0.030
Why?
CpG Islands
1
2016
323
0.030
Why?
Salivary Gland Neoplasms
1
2015
55
0.030
Why?
Systole
1
2015
198
0.030
Why?
Hospital Records
1
2014
8
0.030
Why?
Birth Order
1
2014
7
0.030
Why?
Pilot Projects
1
2019
1391
0.030
Why?
Bevacizumab
1
2014
64
0.030
Why?
Blood Glucose
2
2009
1136
0.030
Why?
Observer Variation
1
2015
299
0.030
Why?
Doxorubicin
2
2010
289
0.030
Why?
Maternal Age
1
2014
134
0.030
Why?
Patient Compliance
1
2017
472
0.030
Why?
DNA Repair
2
2012
585
0.030
Why?
Xenobiotics
1
2013
26
0.030
Why?
Cytochrome P-450 CYP1B1
1
2013
29
0.030
Why?
Endocrine System Diseases
1
2013
39
0.030
Why?
HLA Antigens
1
2014
244
0.030
Why?
Affective Symptoms
1
2013
59
0.030
Why?
Cell Proliferation
2
2010
2285
0.030
Why?
Radiography
1
2015
821
0.030
Why?
Promoter Regions, Genetic
1
2016
1327
0.030
Why?
Sex Factors
1
2016
1287
0.030
Why?
Infant Formula
1
2013
97
0.030
Why?
Maternal-Fetal Exchange
1
2013
81
0.030
Why?
Reproducibility of Results
2
2010
2877
0.030
Why?
Genetic Loci
1
2014
339
0.030
Why?
Angiogenesis Inhibitors
1
2014
204
0.020
Why?
Socioeconomic Factors
1
2016
870
0.020
Why?
Gene Frequency
1
2014
722
0.020
Why?
Glutathione Peroxidase
1
2012
31
0.020
Why?
Multiplex Polymerase Chain Reaction
1
2012
29
0.020
Why?
Medical Records
1
2013
192
0.020
Why?
Metabolic Detoxication, Phase I
1
2012
10
0.020
Why?
Metabolic Detoxication, Phase II
1
2012
14
0.020
Why?
Melanoma
1
1999
835
0.020
Why?
Solvents
1
2012
43
0.020
Why?
Consent Forms
1
2011
22
0.020
Why?
Phosphorylation
2
2010
1614
0.020
Why?
Central Nervous System
1
2013
253
0.020
Why?
Diagnosis, Differential
1
2017
1883
0.020
Why?
Genetic Privacy
1
2011
42
0.020
Why?
Mutation
1
2025
5825
0.020
Why?
Poliovirus Vaccines
1
2011
14
0.020
Why?
Single-Blind Method
1
2011
237
0.020
Why?
Haemophilus Vaccines
1
2011
30
0.020
Why?
Drug Resistance, Neoplasm
2
2010
717
0.020
Why?
Premature Birth
1
2015
385
0.020
Why?
Chi-Square Distribution
1
2012
590
0.020
Why?
Chemokine CXCL6
1
2010
16
0.020
Why?
Hepatitis B Vaccines
1
2011
41
0.020
Why?
Platelet Factor 4
1
2010
22
0.020
Why?
Chemokine CXCL12
1
2010
32
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2014
505
0.020
Why?
Tissue Array Analysis
1
2010
137
0.020
Why?
Mercaptoethylamines
1
2010
1
0.020
Why?
Organs at Risk
1
2010
24
0.020
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2009
20
0.020
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2009
26
0.020
Why?
Echocardiography
1
2015
1052
0.020
Why?
Aurora Kinases
1
2009
31
0.020
Why?
Aged, 80 and over
2
2011
6548
0.020
Why?
Serine
1
2010
173
0.020
Why?
Daunorubicin
1
2009
27
0.020
Why?
Benzazepines
1
2009
62
0.020
Why?
Asparaginase
1
2009
41
0.020
Why?
Pregnancy Complications
1
2014
512
0.020
Why?
Regression Analysis
1
2011
778
0.020
Why?
Informed Consent
1
2011
334
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
1999
82
0.020
Why?
Prednisone
1
2009
275
0.020
Why?
Autistic Disorder
1
2011
342
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
64
0.020
Why?
Feeding Behavior
1
2013
701
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2010
1893
0.020
Why?
Age of Onset
1
2009
591
0.020
Why?
Child Advocacy
1
2007
10
0.020
Why?
Dexamethasone
1
2009
276
0.020
Why?
Patient Advocacy
1
2007
62
0.020
Why?
Down-Regulation
2
1999
699
0.020
Why?
Glucocorticoids
1
2009
381
0.020
Why?
Vaccines
1
2011
366
0.020
Why?
Continuity of Patient Care
1
2007
153
0.020
Why?
Biopsy
1
2009
1237
0.020
Why?
Echocardiography, Doppler, Color
1
2005
112
0.020
Why?
Genome, Human
1
2011
1273
0.010
Why?
Abdominal Neoplasms
1
2004
33
0.010
Why?
Thoracic Neoplasms
1
2004
38
0.010
Why?
Epilepsy
1
2011
871
0.010
Why?
Escherichia coli
1
2009
986
0.010
Why?
Mass Screening
1
2008
782
0.010
Why?
Hospitals, University
1
2001
96
0.010
Why?
bcl-Associated Death Protein
1
1999
4
0.010
Why?
Phosphoserine
1
1999
41
0.010
Why?
bcl-X Protein
1
1999
31
0.010
Why?
bcl-2-Associated X Protein
1
1999
71
0.010
Why?
Cytarabine
1
1999
98
0.010
Why?
Antigens, CD34
1
1999
107
0.010
Why?
Fas Ligand Protein
1
1999
33
0.010
Why?
Jurkat Cells
1
1999
78
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
1999
173
0.010
Why?
Interleukin-2
1
1999
227
0.010
Why?
DNA, Complementary
1
1999
461
0.010
Why?
Interferon-alpha
1
1999
223
0.010
Why?
Doxycycline
1
1998
117
0.010
Why?
Cell Death
1
1998
240
0.010
Why?
Patient Selection
1
2001
695
0.010
Why?
Interferon-gamma
1
1999
502
0.010
Why?
Acute Disease
1
1999
1110
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
1999
1284
0.010
Why?
Transfection
1
1998
1061
0.010
Why?
Adenoviridae
1
1999
606
0.010
Why?
Genetic Vectors
1
1999
940
0.010
Why?
Gene Expression
1
1999
1560
0.010
Why?
DNA Damage
1
1998
513
0.010
Why?
Carrier Proteins
1
1999
1022
0.010
Why?
OKCU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (522)
Explore
_
Co-Authors (112)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_